Global and United States Nucleic Acid Delivery System Market Report & Forecast 2024-2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global and United States Nucleic Acid Delivery System Market Report & Forecast 2024-2034
Nucleic Acid Delivery System (NADS) refers to a range of technologies and methods that are used to deliver nucleic acids, such as DNA or RNA, into cells or tissues. In gene therapy and genetic engineering, NADS play a critical role in delivering therapeutic genes to target cells to treat genetic diseases, as well as in introducing new genetic traits into organisms for various purposes.
The delivery of nucleic acids into cells is challenging due to their large size, negative charge, and susceptibility to degradation by nucleases in the extracellular environment. NADS typically consist of a carrier molecule, such as a lipid or polymer, which can protect the nucleic acids and facilitate their entry into cells. Different types of NADS have been developed over the years, including viral vectors, non-viral vectors, and physical methods such as electroporation and sonoporation.
NADS have become increasingly important in biomedical research and clinical applications, and have shown promising results in treating a variety of genetic diseases, including cystic fibrosis, hemophilia, and muscular dystrophy. They also hold promise for the development of new therapies for cancer and other complex diseases.
Market Analysis and InsightsGlobal and United States Nucleic Acid Delivery System Market
This report focuses on global and United States Nucleic Acid Delivery System market, also covers the segmentation data of other regions in regional level and county level.
The global Nucleic Acid Delivery System revenue was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2033 with a CAGR of % during the review period (2023-2033).
In United States the Nucleic Acid Delivery System revenue is expected to grow from US$ million in 2022 to US$ million by 2033, at a CAGR of % during the forecast period 2023-2033.
The global key players of Nucleic Acid Delivery System include Creative Biogene, Evonik Health Care, Factor Bioscience, Polyplus and AccuRna, etc. The global five biggest players hold a share of % in 2022.
Global Nucleic Acid Delivery System Scope and Market Size
Nucleic Acid Delivery System market is segmented in regional and country level, by players, by Vector and by Application. Companies, stakeholders, and other participants in the global Nucleic Acid Delivery System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Vector and by Application for the period 2018-2033.
For United States market, this report focuses on the Nucleic Acid Delivery System market size by players, by Vector and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in United States.
Creative Biogene
Evonik Health Care
Factor Bioscience
Polyplus
AccuRna
Segment by Vector
Viral Vectors
Lipid-based Carriers
Protein-based Carriers
Drug Development
Gene Therapy
Biopharmaceuticals
Scientific Research
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter 1Introduces Nucleic Acid Delivery System definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by vector, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Nucleic Acid Delivery System companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Nucleic Acid Delivery System in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by vector, by application and by country revenue for each segment.
Chapter 7EMEA by vector, by application and by region, revenue for each segment.
Chapter 8China by vector, by application revenue for each segment.
Chapter 9APAC (excluding China) by vector, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nucleic Acid Delivery System revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions
The delivery of nucleic acids into cells is challenging due to their large size, negative charge, and susceptibility to degradation by nucleases in the extracellular environment. NADS typically consist of a carrier molecule, such as a lipid or polymer, which can protect the nucleic acids and facilitate their entry into cells. Different types of NADS have been developed over the years, including viral vectors, non-viral vectors, and physical methods such as electroporation and sonoporation.
NADS have become increasingly important in biomedical research and clinical applications, and have shown promising results in treating a variety of genetic diseases, including cystic fibrosis, hemophilia, and muscular dystrophy. They also hold promise for the development of new therapies for cancer and other complex diseases.
Market Analysis and InsightsGlobal and United States Nucleic Acid Delivery System Market
This report focuses on global and United States Nucleic Acid Delivery System market, also covers the segmentation data of other regions in regional level and county level.
The global Nucleic Acid Delivery System revenue was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2033 with a CAGR of % during the review period (2023-2033).
In United States the Nucleic Acid Delivery System revenue is expected to grow from US$ million in 2022 to US$ million by 2033, at a CAGR of % during the forecast period 2023-2033.
The global key players of Nucleic Acid Delivery System include Creative Biogene, Evonik Health Care, Factor Bioscience, Polyplus and AccuRna, etc. The global five biggest players hold a share of % in 2022.
Global Nucleic Acid Delivery System Scope and Market Size
Nucleic Acid Delivery System market is segmented in regional and country level, by players, by Vector and by Application. Companies, stakeholders, and other participants in the global Nucleic Acid Delivery System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Vector and by Application for the period 2018-2033.
For United States market, this report focuses on the Nucleic Acid Delivery System market size by players, by Vector and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in United States.
By Company
Creative Biogene
Evonik Health Care
Factor Bioscience
Polyplus
AccuRna
Segment by Vector
Viral Vectors
Lipid-based Carriers
Protein-based Carriers
Segment by Application
Drug Development
Gene Therapy
Biopharmaceuticals
Scientific Research
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter Introduction
Chapter 1Introduces Nucleic Acid Delivery System definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by vector, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Nucleic Acid Delivery System companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Nucleic Acid Delivery System in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by vector, by application and by country revenue for each segment.
Chapter 7EMEA by vector, by application and by region, revenue for each segment.
Chapter 8China by vector, by application revenue for each segment.
Chapter 9APAC (excluding China) by vector, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nucleic Acid Delivery System revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices